Clinical Trial

Coagulation in Cirrhosis

Study acronym: COUCH
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Out of fear of bleeding, liver cirrhosis patients are often treated prophylactically with blood and coagulation products before minor interventions. The COUCH study will examine whether these patients benefit from a restrictive administration of coagulation products.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-27; most recent amendment 2025-01-10.
Status change: Not Yet Recruiting → Recruiting 2023-03-15
Trial Details
NCT Number NCT05667805
Lead Sponsor Medical University of Vienna
Conditions Liver Cirrhosis
Enrollment 400 participants
Start Date 2023-01-19
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-14